Mylan Strikes $463 Million Deal With Novartis for CF Product Line

Mylan Strikes $463 Million Deal With Novartis for CF Product Line

Submitted by admin on September 7, 2018 - 11:03am
Source: 
BioSpace
News Tags: 
Mylan Labs
Novartis
cystic fibrosis
Headline: 
Mylan Strikes $463 Million Deal With Novartis for CF Product Line
snippet: 

Mylan plunked down $463 million for Novartis’ cystic fibrosis products, which includes the TOBI Podhaler and TOBI solution.

Do Not Allow Advertisers to Use My Personal information